- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06380504
Het vergroten van de dekking van de behandeling van ernstige acute ondervoeding (SAM) in Ethiopië (R-SWITCH)
Effect van het benutten van structuren op gemeenschapsniveau om de preventie, screening en behandeling van ernstige acute ondervoeding in Ethiopië te versterken
The R-SWITCH intervention aims to address the low coverage of treatment for severe wasting (SAM) by leveraging existing community groups to deliver an integrated package focused on prevention, screening, referral, and treatment of SAM. It includes behavior change communication on child nutrition and health, active screening, improved passive screening at health posts, and follow-up of referred cases and those enrolled in outpatient treatment programs (OTP). The primary objectives of the R-SWITCH studies are to assess the intervention's impact on OTP coverage, identify implementation barriers and facilitators, and evaluate its cost-efficiency and cost-effectiveness.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Despite the high mortality risk of severe wasting (also referred to as severe acute malnutrition or SAM), only a small proportion of children with severe wasting are currently identified and admitted to available outpatient treatment programs (OTP). In 2020, an estimated 4.9 million children with severe wasting received treatment, approximately a third of the total burden. Outside of humanitarian settings, this proportion is even lower (estimated to be around 15%). These figures highlight the urgent need to increase treatment coverage to meet the Sustainable Development Goals (SDG), which aim to reduce the prevalence of child wasting to less than 5% by 2025 and less than 3% by 2030. The continuum of care for SAM, from case identification, referral to treatment, and post-treatment follow-up, is hampered by several barriers including caregiver lack of awareness on the risks and treatment services of SAM, stigma related to SAM, poor accessibility to treatment, frequent stockouts of treatment inputs, and the overall workload faced by first-line health workers.
The R-SWITCH intervention will leverage existing community groups to deliver an integrated package aimed at preventing SAM through behavior change communication (BCC) on child nutrition and health, increasing wasting screening coverage through active screening, family-led MUAC and improved passive screening health posts, increasing treatment coverage through follow-up of earlier referred cases, cases enrolled in OTP, and children who completed OTP and recovered.
The primary objectives of the R-SWITCH studies are:
- To assess the impact of the R-SWITCH intervention on SAM OTP coverage
- To identify implementation barriers and facilitators
- To assess the cost-efficiency and cost-effectiveness of the intervention package and services
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Lieven Huybregts, PhD
- Telefoonnummer: +1 202 862-6481
- E-mail: l.huybregts@cgiar.org
Studie Contact Back-up
- Naam: Alemayehu Haddis, PhD
- E-mail: alemayehuh@etpha.org
Studie Locaties
-
-
-
Jimma, Ethiopië
- Werving
- Kersa and Jeldessa woredas
-
Hoofdonderzoeker:
- Lieven Huybregts, PhD
-
Hoofdonderzoeker:
- Tefera Belachew, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Child 6-59 months of age
- Suffering from SAM (defined as MUAC < 115mm or presence of bilateral pitting edema or Weight-for-Length Z-score <-3) OR currently enrolled in SAM OTP
Exclusion Criteria:
- Anthropometric malformation or being handicapped which hampers anthropometric measurements.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Standard of Care
|
|
|
Experimenteel: R-SWITCH integrated intervention package
|
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Period prevalence of SAM OTP treatment coverage in children 6-59 months of age
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children with Severe Acute Malnutrition (SAM) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".
|
After 24 months of program implementation
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Point prevalence of SAM OTP treatment coverage in children 6-59 months of age
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome |
After 24 months of program implementation
|
|
Period prevalence of SAM OTP treatment coverage in the subgroup of treatment eligible children 6-59 months of age
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children with Severe Acute Malnutrition (SAM) or Severe underweight (weight-for-age Z-score <-3) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".
|
After 24 months of program implementation
|
|
Screening coverage of SAM
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver) |
After 24 months of program implementation
|
|
Screening coverage of severe underweight
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with severe underweight (weight-for-age Z-score <-3 relative to WHO 2006 growth standard) screened over the last 30 days (as reported by the caregiver) |
After 24 months of program implementation
|
|
Platform specific screening coverage of SAM
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver):
|
After 24 months of program implementation
|
|
Growth Monitoring Promotion (GMP) consultation attendance
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM that attended GMP over the last 30 days (as reported by the caregiver). |
After 24 months of program implementation
|
|
AFD group meeting attendance
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of of children aged 6-59 months with SAM that attended the monthly AFD group contact over the last 30 days (as reported by the caregiver). |
After 24 months of program implementation
|
|
AFD home visit coverage
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM and children enrolled in SAM OTP that received a home visit by an AFD leader/member over the last 30 days (as reported by the caregiver). |
After 24 months of program implementation
|
|
Prevalence of SAM
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ <-3 or a MUAC < 115 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Prevalence of wasting
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Prevalence of stunting
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with stunting (defined as height-for-age Z-scores (HAZ) <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate HAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Prevalence of underweight and severe underweight
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with underweight (defined as weight-for-age Z-scores (WAZ) <-2 ) and severe underweight (defined as WAZ <-3 ). To calculate WAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean height-for-age Z-score (HAZ)
Tijdsspanne: After 24 months of program implementation
|
In 6-59 months old children. To calculate HAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean weight-for-height Z-score (WHZ)
Tijdsspanne: After 24 months of program implementation
|
In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean weight-for-age Z-score (WAZ)
Tijdsspanne: After 24 months of program implementation
|
In 6-59 months old children.To calculate WAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean mid-upper arm circumference (MUAC)
Tijdsspanne: After 24 months of program implementation
|
In 6-59 months old children. |
After 24 months of program implementation
|
|
Caregiver's knowledge related to breastfeeding, complementary feeding,child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting
Tijdsspanne: After 24 months of program implementation
|
Presented as a total standardized score and by knowledge domain |
After 24 months of program implementation
|
|
Vaccination coverage
Tijdsspanne: After 24 months of program implementation
|
Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all age-recommended immunizations |
After 24 months of program implementation
|
|
Introduction of (semi) solid and soft complementary foods
Tijdsspanne: After 24 months of program implementation
|
The proportion of children 6-8 months of age who consumed (semi) solid and soft complementary foods during the previous day |
After 24 months of program implementation
|
|
Minimum dietary diversity in infants and young children (6-23 mo)
Tijdsspanne: After 24 months of program implementation
|
The proportion of study children aged 6-23 months who consumed at least 5 of the 8 food groups (including breast milk) during the previous day |
After 24 months of program implementation
|
|
Nr of food groups consumed by infants and young children (6-59 mo)
Tijdsspanne: After 24 months of program implementation
|
The mean number of food groups consumed during the previous day by study children aged 6-59 |
After 24 months of program implementation
|
|
Minimum meal frequency in infants and young children
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of study children who had eaten during the previous day: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 monthsMinimum meal frequency for children, defined as the proportion of children who had eaten the day before the survey: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 months. |
After 24 months of program implementation
|
|
Minimum acceptable diet in infants and young children
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of study children aged 6-23 months with both minimal dietary diversity and minimal meal frequency during the previous day |
After 24 months of program implementation
|
|
Continuous breastfeeding 12-23 months
Tijdsspanne: After 24 months of program implementation
|
Defined as the proportion of children aged 12-23 months breastfed during the previous day |
After 24 months of program implementation
|
|
Egg and/or flesh food consumption
Tijdsspanne: After 24 months of program implementation
|
Proportion of children 6-23 months of age who consumed egg and/or flesh food during the previous day |
After 24 months of program implementation
|
|
Sweet beverage consumption
Tijdsspanne: After 24 months of program implementation
|
Proportion of children 6-23 months of age who consumed a sweet beverage during the previous day |
After 24 months of program implementation
|
|
Zero vegetable or fruit consumption consumption
Tijdsspanne: After 24 months of program implementation
|
Proportion of children 6-23 months of age who did not consume any vegetables or fruits during the previous day |
After 24 months of program implementation
|
|
Minimum milk feeding frequency for non-breastfed children
Tijdsspanne: After 24 months of program implementation
|
Proportion of non-breastfed children 6-23 months of age who consumed at least two milk feeds during the previous day |
After 24 months of program implementation
|
|
Weight-for-length Z-score and MUAC at Severe Acute Malnutrition (SAM) Outpatient Therapeutic Feeding program (OTP)
Tijdsspanne: 24 months from baseline until endline of the study
|
Weight-for-length Z-score (relative to the 2006 WHO reference) and MUAC(mm) |
24 months from baseline until endline of the study
|
|
SAM OTP adherence
Tijdsspanne: 24 months from baseline until endline of the study
|
Defined as the proportion of cases enrolled to SAM OTP who received timely treatment from dedicated services (health center or health post) until anthropometric recovery |
24 months from baseline until endline of the study
|
|
Weight gain rate during SAM OTP
Tijdsspanne: 24 months from baseline until endline of the study
|
Defined as the weight gain during SAM OTP divided by the length of treatment and divided by the child's weight |
24 months from baseline until endline of the study
|
|
SAM OTP outcomes (drop-out, death, transfer, non-response rates)
Tijdsspanne: 24 months from baseline until endline of the study
|
Among cases admitted to SAM OTP |
24 months from baseline until endline of the study
|
|
SAM OTP duration
Tijdsspanne: 24 months from baseline until endline of the study
|
Defined as the number of days spent in SAM OTP (from admission to discharge) |
24 months from baseline until endline of the study
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Lieven Huybregts, PhD, International Food Policy Research Institute
- Hoofdonderzoeker: Tefera Belachew, PhD, Ethiopian Public Health Association
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RSWITCH-Ethiopia
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .